A Retrospective Study Investigating the Effect of Repeated Exposure to Multiple Administrations of the Macrocyclic Gadolinium-Based Contrast Agent (GBCA) Gadoterate Meglumine on Signal Intensity at Unenhanced T1-Weighted Magnetic Resonance in the Globus Pallidus and Dentate Nucleus in a Pediatric Population

Trial Profile

A Retrospective Study Investigating the Effect of Repeated Exposure to Multiple Administrations of the Macrocyclic Gadolinium-Based Contrast Agent (GBCA) Gadoterate Meglumine on Signal Intensity at Unenhanced T1-Weighted Magnetic Resonance in the Globus Pallidus and Dentate Nucleus in a Pediatric Population

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Apr 2018

At a glance

  • Drugs Gadoterate-meglumine (Primary)
  • Indications CNS disorders; Vascular disorders
  • Focus Diagnostic use
  • Most Recent Events

    • 11 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top